aluates Reports

$ 0.0

Automative

Global Oxaliplatin Market Research Report 2026

Published Date: 2026-01-26

Report Code: QYRE-Auto-5N9258

Global Oxaliplatin Market Insights and Forecast to 2028

BUY CHAPTERS

Global Oxaliplatin Market Research Report 2026

Code: QYRE-Auto-5N9258

Report

2026-01-26

Pages:134

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi Aventis

Yakult honsha

Dr. Reddy’s Laboratories

Sun Pharmaceutical

TEVA

Jiangsu Hengrui Medicine

Nanjing Pharmaceutical Factory

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Hisun Pharmaceutical

Lunan Pharmaceutical

Luoxin

Halfsky Pharmacy

YRPG

Hainan Jinrui Pharmaceutical

Jari Pharmaceutical

Chiatai Tianqing

Hospira

Fresenius Kabi

Mylan NV

Oxaliplatin Market Size

The global Oxaliplatin market was valued at US$ 1148 million in 2025 and is anticipated to reach US$ 2068 million by 2032, at a CAGR of 8.9% from 2026 to 2032.

Oxaliplatin Market

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy"s laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.

This report delivers a comprehensive overview of the global Oxaliplatin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oxaliplatin. The Oxaliplatin market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Oxaliplatin market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Oxaliplatin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Oxaliplatin Market Report

Report Metric	Details
Report Name	Oxaliplatin Market
Accounted market size in 2025	US$ 1148 million
Forecasted market size in 2032	US$ 2068 million
CAGR	8.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Mannitol Glucose Solution Lactose Solution Others
Segment by Application	Colorectal Cancer Stomach Cancer Ovarian Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oxaliplatin companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Oxaliplatin Market growing?

Ans: The Oxaliplatin Market witnessing a CAGR of 8.9% during the forecast period 2026-2032.

What is the Oxaliplatin Market size in 2032?

Ans: The Oxaliplatin Market size in 2032 will be US$ 2068 million.

What is the Oxaliplatin Market share by region?

Ans: Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

What is the market share of major companies in Oxaliplatin Market?

Ans: Top 3 companies occupied about 66% revenue market share.

Who are the main players in the Oxaliplatin Market report?

Ans: The main players in the Oxaliplatin Market are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing

What are the Application segmentation covered in the Oxaliplatin Market report?

Ans: The Applications covered in the Oxaliplatin Market report are Colorectal Cancer, Stomach Cancer, Ovarian Cancer, Others

What are the Type segmentation covered in the Oxaliplatin Market report?

Ans: The Types covered in the Oxaliplatin Market report are Mannitol, Glucose Solution, Lactose Solution, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oxaliplatin Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Mannitol

1.2.3 Glucose Solution

1.2.4 Lactose Solution

1.2.5 Others

1.3 Market by Application

1.3.1 Global Oxaliplatin Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Colorectal Cancer

1.3.3 Stomach Cancer

1.3.4 Ovarian Cancer

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oxaliplatin Market Perspective (2021–2032)

2.2 Global Oxaliplatin Growth Trends by Region

2.2.1 Global Oxaliplatin Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Oxaliplatin Historic Market Size by Region (2021–2026)

2.2.3 Oxaliplatin Forecasted Market Size by Region (2027–2032)

2.3 Oxaliplatin Market Dynamics

2.3.1 Oxaliplatin Industry Trends

2.3.2 Oxaliplatin Market Drivers

2.3.3 Oxaliplatin Market Challenges

2.3.4 Oxaliplatin Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oxaliplatin Players by Revenue

3.1.1 Global Top Oxaliplatin Players by Revenue (2021–2026)

3.1.2 Global Oxaliplatin Revenue Market Share by Players (2021–2026)

3.2 Global Top Oxaliplatin Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Oxaliplatin Revenue

3.4 Global Oxaliplatin Market Concentration Ratio

3.4.1 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oxaliplatin Revenue in 2025

3.5 Global Key Players of Oxaliplatin Head Offices and Areas Served

3.6 Global Key Players of Oxaliplatin, Products and Applications

3.7 Global Key Players of Oxaliplatin, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Oxaliplatin Breakdown Data by Type

4.1 Global Oxaliplatin Historic Market Size by Type (2021–2026)

4.2 Global Oxaliplatin Forecasted Market Size by Type (2027–2032)

5 Oxaliplatin Breakdown Data by Application

5.1 Global Oxaliplatin Historic Market Size by Application (2021–2026)

5.2 Global Oxaliplatin Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Oxaliplatin Market Size (2021–2032)

6.2 North America Oxaliplatin Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Oxaliplatin Market Size by Country (2021–2026)

6.4 North America Oxaliplatin Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oxaliplatin Market Size (2021–2032)

7.2 Europe Oxaliplatin Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Oxaliplatin Market Size by Country (2021–2026)

7.4 Europe Oxaliplatin Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Oxaliplatin Market Size (2021–2032)

8.2 Asia-Pacific Oxaliplatin Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Oxaliplatin Market Size by Region (2021–2026)

8.4 Asia-Pacific Oxaliplatin Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Oxaliplatin Market Size (2021–2032)

9.2 Latin America Oxaliplatin Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Oxaliplatin Market Size by Country (2021–2026)

9.4 Latin America Oxaliplatin Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oxaliplatin Market Size (2021–2032)

10.2 Middle East & Africa Oxaliplatin Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Oxaliplatin Market Size by Country (2021–2026)

10.4 Middle East & Africa Oxaliplatin Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi-Aventis

11.1.1 Sanofi-Aventis Company Details

11.1.2 Sanofi-Aventis Business Overview

11.1.3 Sanofi-Aventis Oxaliplatin Introduction

11.1.4 Sanofi-Aventis Revenue in Oxaliplatin Business (2021–2026)

11.1.5 Sanofi-Aventis Recent Development

11.2 Yakult honsha

11.2.1 Yakult honsha Company Details

11.2.2 Yakult honsha Business Overview

11.2.3 Yakult honsha Oxaliplatin Introduction

11.2.4 Yakult honsha Revenue in Oxaliplatin Business (2021–2026)

11.2.5 Yakult honsha Recent Development

11.3 Dr Reddy's laboratories

11.3.1 Dr Reddy's laboratories Company Details

11.3.2 Dr Reddy's laboratories Business Overview

11.3.3 Dr Reddy's laboratories Oxaliplatin Introduction

11.3.4 Dr Reddy's laboratories Revenue in Oxaliplatin Business (2021–2026)

11.3.5 Dr Reddy's laboratories Recent Development

11.4 Sun Pharmaceutical

11.4.1 Sun Pharmaceutical Company Details

11.4.2 Sun Pharmaceutical Business Overview

11.4.3 Sun Pharmaceutical Oxaliplatin Introduction

11.4.4 Sun Pharmaceutical Revenue in Oxaliplatin Business (2021–2026)

11.4.5 Sun Pharmaceutical Recent Development

11.5 Teva

11.5.1 Teva Company Details

11.5.2 Teva Business Overview

11.5.3 Teva Oxaliplatin Introduction

11.5.4 Teva Revenue in Oxaliplatin Business (2021–2026)

11.5.5 Teva Recent Development

11.6 Fresenius Kabi

11.6.1 Fresenius Kabi Company Details

11.6.2 Fresenius Kabi Business Overview

11.6.3 Fresenius Kabi Oxaliplatin Introduction

11.6.4 Fresenius Kabi Revenue in Oxaliplatin Business (2021–2026)

11.6.5 Fresenius Kabi Recent Development

11.7 Hospira

11.7.1 Hospira Company Details

11.7.2 Hospira Business Overview

11.7.3 Hospira Oxaliplatin Introduction

11.7.4 Hospira Revenue in Oxaliplatin Business (2021–2026)

11.7.5 Hospira Recent Development

11.8 Mylan

11.8.1 Mylan Company Details

11.8.2 Mylan Business Overview

11.8.3 Mylan Oxaliplatin Introduction

11.8.4 Mylan Revenue in Oxaliplatin Business (2021–2026)

11.8.5 Mylan Recent Development

11.9 Jiangsu Hengrui Medicine

11.9.1 Jiangsu Hengrui Medicine Company Details

11.9.2 Jiangsu Hengrui Medicine Business Overview

11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Introduction

11.9.4 Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2021–2026)

11.9.5 Jiangsu Hengrui Medicine Recent Development

11.10 Nanjing Pharmaceutical Factory

11.10.1 Nanjing Pharmaceutical Factory Company Details

11.10.2 Nanjing Pharmaceutical Factory Business Overview

11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Introduction

11.10.4 Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2021–2026)

11.10.5 Nanjing Pharmaceutical Factory Recent Development

11.11 Jiangsu Aosaikang Pharmaceutical

11.11.1 Jiangsu Aosaikang Pharmaceutical Company Details

11.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview

11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Introduction

11.11.4 Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2021–2026)

11.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development

11.12 Qilu Pharmaceutical

11.12.1 Qilu Pharmaceutical Company Details

11.12.2 Qilu Pharmaceutical Business Overview

11.12.3 Qilu Pharmaceutical Oxaliplatin Introduction

11.12.4 Qilu Pharmaceutical Revenue in Oxaliplatin Business (2021–2026)

11.12.5 Qilu Pharmaceutical Recent Development

11.13 Hisun Pharmaceutical

11.13.1 Hisun Pharmaceutical Company Details

11.13.2 Hisun Pharmaceutical Business Overview

11.13.3 Hisun Pharmaceutical Oxaliplatin Introduction

11.13.4 Hisun Pharmaceutical Revenue in Oxaliplatin Business (2021–2026)

11.13.5 Hisun Pharmaceutical Recent Development

11.14 Lunan Pharmaceutical

11.14.1 Lunan Pharmaceutical Company Details

11.14.2 Lunan Pharmaceutical Business Overview

11.14.3 Lunan Pharmaceutical Oxaliplatin Introduction

11.14.4 Lunan Pharmaceutical Revenue in Oxaliplatin Business (2021–2026)

11.14.5 Lunan Pharmaceutical Recent Development

11.15 Luoxin

11.15.1 Luoxin Company Details

11.15.2 Luoxin Business Overview

11.15.3 Luoxin Oxaliplatin Introduction

11.15.4 Luoxin Revenue in Oxaliplatin Business (2021–2026)

11.15.5 Luoxin Recent Development

11.16 Halfsky Pharmacy

11.16.1 Halfsky Pharmacy Company Details

11.16.2 Halfsky Pharmacy Business Overview

11.16.3 Halfsky Pharmacy Oxaliplatin Introduction

11.16.4 Halfsky Pharmacy Revenue in Oxaliplatin Business (2021–2026)

11.16.5 Halfsky Pharmacy Recent Development

11.17 YRPG

11.17.1 YRPG Company Details

11.17.2 YRPG Business Overview

11.17.3 YRPG Oxaliplatin Introduction

11.17.4 YRPG Revenue in Oxaliplatin Business (2021–2026)

11.17.5 YRPG Recent Development

11.18 Hainan Jinrui Pharmaceutical

11.18.1 Hainan Jinrui Pharmaceutical Company Details

11.18.2 Hainan Jinrui Pharmaceutical Business Overview

11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Introduction

11.18.4 Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2021–2026)

11.18.5 Hainan Jinrui Pharmaceutical Recent Development

11.19 Jari Pharmaceutical

11.19.1 Jari Pharmaceutical Company Details

11.19.2 Jari Pharmaceutical Business Overview

11.19.3 Jari Pharmaceutical Oxaliplatin Introduction

11.19.4 Jari Pharmaceutical Revenue in Oxaliplatin Business (2021–2026)

11.19.5 Jari Pharmaceutical Recent Development

11.20 Chiatai Tianqing

11.20.1 Chiatai Tianqing Company Details

11.20.2 Chiatai Tianqing Business Overview

11.20.3 Chiatai Tianqing Oxaliplatin Introduction

11.20.4 Chiatai Tianqing Revenue in Oxaliplatin Business (2021–2026)

11.20.5 Chiatai Tianqing Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi Aventis

Yakult honsha

Dr. Reddy’s Laboratories

Sun Pharmaceutical

TEVA

Jiangsu Hengrui Medicine

Nanjing Pharmaceutical Factory

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Hisun Pharmaceutical

Lunan Pharmaceutical

Luoxin

Halfsky Pharmacy

YRPG

Hainan Jinrui Pharmaceutical

Jari Pharmaceutical

Chiatai Tianqing

Hospira

Fresenius Kabi

Mylan NV

List of Tables

Table 1. Global Oxaliplatin Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Mannitol

Table 3. Key Players of Glucose Solution

Table 4. Key Players of Lactose Solution

Table 5. Key Players of Others

Table 6. Global Oxaliplatin Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Oxaliplatin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Oxaliplatin Market Size by Region (US$ Million), 2021–2026

Table 9. Global Oxaliplatin Market Share by Region (2021–2026)

Table 10. Global Oxaliplatin Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Oxaliplatin Market Share by Region (2027–2032)

Table 12. Oxaliplatin Market Trends

Table 13. Oxaliplatin Market Drivers

Table 14. Oxaliplatin Market Challenges

Table 15. Oxaliplatin Market Restraints

Table 16. Global Oxaliplatin Revenue by Players (US$ Million), 2021–2026

Table 17. Global Oxaliplatin Market Share by Players (2021–2026)

Table 18. Global Top Oxaliplatin Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oxaliplatin Revenue, 2025

Table 19. Ranking of Global Top Oxaliplatin Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Oxaliplatin Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Oxaliplatin, Headquarters and Area Served

Table 22. Global Key Players of Oxaliplatin, Products and Applications

Table 23. Global Key Players of Oxaliplatin, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Oxaliplatin Market Size by Type (US$ Million), 2021–2026

Table 26. Global Oxaliplatin Revenue Market Share by Type (2021–2026)

Table 27. Global Oxaliplatin Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Oxaliplatin Revenue Market Share by Type (2027–2032)

Table 29. Global Oxaliplatin Market Size by Application (US$ Million), 2021–2026

Table 30. Global Oxaliplatin Revenue Market Share by Application (2021–2026)

Table 31. Global Oxaliplatin Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Oxaliplatin Revenue Market Share by Application (2027–2032)

Table 33. North America Oxaliplatin Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Oxaliplatin Market Size by Country (US$ Million), 2021–2026

Table 35. North America Oxaliplatin Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Oxaliplatin Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Oxaliplatin Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Oxaliplatin Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Oxaliplatin Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Oxaliplatin Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Oxaliplatin Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Oxaliplatin Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Oxaliplatin Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Oxaliplatin Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Oxaliplatin Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Oxaliplatin Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Oxaliplatin Market Size by Country (US$ Million), 2027–2032

Table 48. Sanofi-Aventis Company Details

Table 49. Sanofi-Aventis Business Overview

Table 50. Sanofi-Aventis Oxaliplatin Product

Table 51. Sanofi-Aventis Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 52. Sanofi-Aventis Recent Development

Table 53. Yakult honsha Company Details

Table 54. Yakult honsha Business Overview

Table 55. Yakult honsha Oxaliplatin Product

Table 56. Yakult honsha Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 57. Yakult honsha Recent Development

Table 58. Dr Reddy's laboratories Company Details

Table 59. Dr Reddy's laboratories Business Overview

Table 60. Dr Reddy's laboratories Oxaliplatin Product

Table 61. Dr Reddy's laboratories Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 62. Dr Reddy's laboratories Recent Development

Table 63. Sun Pharmaceutical Company Details

Table 64. Sun Pharmaceutical Business Overview

Table 65. Sun Pharmaceutical Oxaliplatin Product

Table 66. Sun Pharmaceutical Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 67. Sun Pharmaceutical Recent Development

Table 68. Teva Company Details

Table 69. Teva Business Overview

Table 70. Teva Oxaliplatin Product

Table 71. Teva Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 72. Teva Recent Development

Table 73. Fresenius Kabi Company Details

Table 74. Fresenius Kabi Business Overview

Table 75. Fresenius Kabi Oxaliplatin Product

Table 76. Fresenius Kabi Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 77. Fresenius Kabi Recent Development

Table 78. Hospira Company Details

Table 79. Hospira Business Overview

Table 80. Hospira Oxaliplatin Product

Table 81. Hospira Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 82. Hospira Recent Development

Table 83. Mylan Company Details

Table 84. Mylan Business Overview

Table 85. Mylan Oxaliplatin Product

Table 86. Mylan Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 87. Mylan Recent Development

Table 88. Jiangsu Hengrui Medicine Company Details

Table 89. Jiangsu Hengrui Medicine Business Overview

Table 90. Jiangsu Hengrui Medicine Oxaliplatin Product

Table 91. Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 92. Jiangsu Hengrui Medicine Recent Development

Table 93. Nanjing Pharmaceutical Factory Company Details

Table 94. Nanjing Pharmaceutical Factory Business Overview

Table 95. Nanjing Pharmaceutical Factory Oxaliplatin Product

Table 96. Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 97. Nanjing Pharmaceutical Factory Recent Development

Table 98. Jiangsu Aosaikang Pharmaceutical Company Details

Table 99. Jiangsu Aosaikang Pharmaceutical Business Overview

Table 100. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product

Table 101. Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 102. Jiangsu Aosaikang Pharmaceutical Recent Development

Table 103. Qilu Pharmaceutical Company Details

Table 104. Qilu Pharmaceutical Business Overview

Table 105. Qilu Pharmaceutical Oxaliplatin Product

Table 106. Qilu Pharmaceutical Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 107. Qilu Pharmaceutical Recent Development

Table 108. Hisun Pharmaceutical Company Details

Table 109. Hisun Pharmaceutical Business Overview

Table 110. Hisun Pharmaceutical Oxaliplatin Product

Table 111. Hisun Pharmaceutical Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 112. Hisun Pharmaceutical Recent Development

Table 113. Lunan Pharmaceutical Company Details

Table 114. Lunan Pharmaceutical Business Overview

Table 115. Lunan Pharmaceutical Oxaliplatin Product

Table 116. Lunan Pharmaceutical Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 117. Lunan Pharmaceutical Recent Development

Table 118. Luoxin Company Details

Table 119. Luoxin Business Overview

Table 120. Luoxin Oxaliplatin Product

Table 121. Luoxin Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 122. Luoxin Recent Development

Table 123. Halfsky Pharmacy Company Details

Table 124. Halfsky Pharmacy Business Overview

Table 125. Halfsky Pharmacy Oxaliplatin Product

Table 126. Halfsky Pharmacy Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 127. Halfsky Pharmacy Recent Development

Table 128. YRPG Company Details

Table 129. YRPG Business Overview

Table 130. YRPG Oxaliplatin Product

Table 131. YRPG Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 132. YRPG Recent Development

Table 133. Hainan Jinrui Pharmaceutical Company Details

Table 134. Hainan Jinrui Pharmaceutical Business Overview

Table 135. Hainan Jinrui Pharmaceutical Oxaliplatin Product

Table 136. Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 137. Hainan Jinrui Pharmaceutical Recent Development

Table 138. Jari Pharmaceutical Company Details

Table 139. Jari Pharmaceutical Business Overview

Table 140. Jari Pharmaceutical Oxaliplatin Product

Table 141. Jari Pharmaceutical Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 142. Jari Pharmaceutical Recent Development

Table 143. Chiatai Tianqing Company Details

Table 144. Chiatai Tianqing Business Overview

Table 145. Chiatai Tianqing Oxaliplatin Product

Table 146. Chiatai Tianqing Revenue in Oxaliplatin Business (US$ Million), 2021–2026

Table 147. Chiatai Tianqing Recent Development

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Oxaliplatin Picture

Figure 2. Global Oxaliplatin Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Oxaliplatin Market Share by Type: 2025 vs 2032

Figure 4. Mannitol Features

Figure 5. Glucose Solution Features

Figure 6. Lactose Solution Features

Figure 7. Others Features

Figure 8. Global Oxaliplatin Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Oxaliplatin Market Share by Application: 2025 vs 2032

Figure 10. Colorectal Cancer Case Studies

Figure 11. Stomach Cancer Case Studies

Figure 12. Ovarian Cancer Case Studies

Figure 13. Others Case Studies

Figure 14. Oxaliplatin Report Years Considered

Figure 15. Global Oxaliplatin Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Oxaliplatin Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Oxaliplatin Market Share by Region: 2025 vs 2032

Figure 18. Global Oxaliplatin Market Share by Players in 2025

Figure 19. Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Oxaliplatin Revenue in 2025

Figure 21. North America Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Oxaliplatin Market Share by Country (2021–2032)

Figure 23. United States Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Oxaliplatin Market Share by Country (2021–2032)

Figure 27. Germany Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Oxaliplatin Market Share by Region (2021–2032)

Figure 35. China Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Oxaliplatin Market Share by Country (2021–2032)

Figure 43. Mexico Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Oxaliplatin Market Share by Country (2021–2032)

Figure 47. Israel Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Oxaliplatin Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Sanofi-Aventis Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 51. Yakult honsha Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 52. Dr Reddy's laboratories Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 53. Sun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 54. Teva Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 55. Fresenius Kabi Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 56. Hospira Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 57. Mylan Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 58. Jiangsu Hengrui Medicine Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 59. Nanjing Pharmaceutical Factory Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 60. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 61. Qilu Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 62. Hisun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 63. Lunan Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 64. Luoxin Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 65. Halfsky Pharmacy Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 66. YRPG Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 67. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 68. Jari Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 69. Chiatai Tianqing Revenue Growth Rate in Oxaliplatin Business (2021–2026)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Platinum based Anticancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oxaliplatin Injection Market Research Report 2024

Global Cisplatin Market Research Report 2024

Cisplatin Chemotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Platinum Compounds Market Research Report 2024

Global Carboplatin Market Research Report 2025

Platinum Anti tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Irinotecan Market Research Report 2024

Global Taxane Antineoplastic Drug Market Research Report 2024

Arranon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oxaliplatin API Market Research Report 2024

Global Platinum based Antineoplastic Market Research Report 2025

Global Carboplatin API Market Research Report 2024

Colorectal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cisplatin API Market Research Report 2024

Global Niraparib API Market Research Report 2024

Global Vinorelbine Market Research Report 2024

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Platinum based Anticancer APIs Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions